Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$2.48 - $9.65 $87,437 - $340,230
-35,257 Reduced 10.72%
293,611 $2.82 Million
Q4 2022

Feb 14, 2023

BUY
$2.1 - $3.34 $39,480 - $62,792
18,800 Added 6.06%
328,868 $1.04 Million
Q3 2022

Nov 14, 2022

SELL
$2.0 - $3.56 $37,600 - $66,928
-18,800 Reduced 5.72%
310,068 $933,000
Q2 2022

Aug 15, 2022

SELL
$2.49 - $7.86 $52,618 - $166,097
-21,132 Reduced 6.04%
328,868 $819,000
Q1 2022

May 16, 2022

SELL
$4.53 - $8.57 $3.17 Million - $5.99 Million
-698,956 Reduced 66.63%
350,000 $2.72 Million
Q4 2021

Feb 14, 2022

BUY
$4.17 - $7.78 $796,236 - $1.49 Million
190,944 Added 22.25%
1,048,956 $4.37 Million
Q3 2021

Nov 15, 2021

SELL
$7.83 - $9.41 $134,120 - $161,183
-17,129 Reduced 1.96%
858,012 $6.8 Million
Q2 2021

Aug 16, 2021

BUY
$7.97 - $10.66 $997,373 - $1.33 Million
125,141 Added 16.69%
875,141 $7.07 Million
Q1 2021

May 17, 2021

BUY
$9.75 - $13.09 $1.95 Million - $2.62 Million
200,000 Added 36.36%
750,000 $8.04 Million
Q4 2020

Feb 16, 2021

BUY
$11.5 - $13.73 $6.33 Million - $7.55 Million
550,000 New
550,000 $6.46 Million
Q3 2020

Nov 16, 2020

SELL
$11.8 - $17.1 $708,000 - $1.03 Million
-60,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$17.0 - $17.78 $1.02 Million - $1.07 Million
60,000 New
60,000 $1.05 Million

Others Institutions Holding FUSN

About Fusion Pharmaceuticals Inc.


  • Ticker FUSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,390,500
  • Description
  • Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...
More about FUSN
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.